TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Transthyretin Amyloidosis With Cardiomyopathy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Clinical Trial Site, La Jolla, California, United States

  • Clinical Trial Site, Stanford, California, United States

  • Clinical Trial Site, Norwich, Connecticut, United States

  • Clinical Trial Site, Washington D.C., District of Columbia, United States

  • Clinical Trial Site, Brandon, Florida, United States

  • Clinical Trial Site, Miami, Florida, United States

  • Clinical Trial Site, Atlanta, Georgia, United States

  • Clinical Trial Site, Gainesville, Georgia, United States

  • Clinical Trial Site, Tucker, Georgia, United States

  • Clinical Trial Site, Evanston, Illinois, United States

  • Clinical Trial Site, Indianapolis, Indiana, United States

  • Clinical Trial Site, Indianapolis, Indiana, United States

  • Clinical Trial Site, Kansas City, Kansas, United States

  • Clinical Trial Site, Baltimore, Maryland, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

  • Clinical Trial Site, Boston, Massachusetts, United States

  • Clinical Trial Site, Detroit, Michigan, United States

  • Clinical Trial Site, Rochester, Minnesota, United States

  • Clinical Trial Site, St Louis, Missouri, United States

  • Clinical Trial Site, Manhasset, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, The Bronx, New York, United States

  • Clinical Trial Site, Charlotte, North Carolina, United States

  • Clinical Trial Site, Cleveland, Ohio, United States

  • Clinical Trial Site, Portland, Oregon, United States

  • Clinical Trial Site, Lancaster, Pennsylvania, United States

  • Clinical Trial Site, Philadelphia, Pennsylvania, United States

  • Clinical Trial Site, Charleston, South Carolina, United States

  • Clinical Trial Site, Dallas, Texas, United States

  • Clinical Trial Site, Houston, Texas, United States

  • Clinical Trial Site, Plano, Texas, United States

  • Clinical Trial Site, Salt Lake City, Utah, United States

  • Clinical Trial Site, Charlottesville, Virginia, United States

  • Clinical Trial Site, Falls Church, Virginia, United States

  • Clinical Trial Site, Norfolk, Virginia, United States

  • Clinical Trial Site, Richmond, Virginia, United States

  • Clinical Trial Site, Spokane, Washington, United States

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Buenos Aires, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Rosario, Argentina

  • Clinical Trial Site, Adelaide, Australia

  • Clinical Trial Site, Bedford Park, Australia

  • Clinical Trial Site, Box Hill, Australia

  • Clinical Trial Site, Chermside, Australia

  • Clinical Trial Site, Darlinghurst, Australia

  • Clinical Trial Site, Joondalup, Australia

  • Clinical Trial Site, Westmead, Australia

  • Clinical Trial Site, Braunau am Inn, Austria

  • Clinical Trial Site, Graz, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Vienna, Austria

  • Clinical Trial Site, Wels, Austria

  • Clinical Trial Site, Aalst, Belgium

  • Clinical Trial Site, Bruges, Belgium

  • Clinical Trial Site, Brussels, Belgium

  • Clinical Trial Site, Dendermonde, Belgium

  • Clinical Trial Site, Genk, Belgium

  • Clinical Trial Site, Ghent, Belgium

  • Clinical Trial Site, Hasselt, Belgium

  • Clinical Trial Site, Leuven, Belgium

  • Clinical Trial Site, Liège, Belgium

  • Clinical Trial Site, Roeselare, Belgium

  • Clinical Trial Site, Belo Horizonte, Brazil

  • Clinical Trial Site, Porto Alegre, Brazil

  • Clinical Trial Site, Porto Alegre, Brazil

  • Clinical Trial Site, Ribeirão Preto, Brazil

  • Clinical Trial Site, Ribeirão Preto, Brazil

  • Clinical Trial Site, Salvador, Brazil

  • Clinical Trial Site, São Paulo, Brazil

  • Clinical Trial Site, São Paulo, Brazil

  • Clinical Trial Site, Calgary, Canada

  • Clinical Trial Site, London, Canada

  • Clinical Trial Site, Santiago, Chile

  • Clinical Trial Site, Santiago, Chile

  • Clinical Trial Site, Dongcheng, China

  • Clinical Trial Site, Haidian, China

  • Clinical Trial Site, Brno, Czechia

  • Clinical Trial Site, Ostrava, Czechia

  • Clinical Trial Site, Prague, Czechia

  • Clinical Trial Site, Prague, Czechia

  • Clinical Trial Site, Aarhus N, Denmark

  • Clinical Trial Site, København Ø, Denmark

  • Clinical Trial Site, Odense C, Denmark

  • Clinical Trial Site, Chambray-lès-Tours, France

  • Clinical Trial Site, Créteil, France

  • Clinical Trial Site, Dijon, France

  • Clinical Trial Site, La Tronche, France

  • Clinical Trial Site, Marseille, France

  • Clinical Trial Site, Martinique, France

  • Clinical Trial Site, Montpellier, France

  • Clinical Trial Site, Paris, France

  • Clinical Trial Site, Paris, France

  • Clinical Trial Site, Pessac, France

  • Clinical Trial Site, Reims, France

  • Clinical Trial Site, Rennes, France

  • Clinical Trial Site, Rouen, France

  • Clinical Trial Site, Saint-Herblain, France

  • Clinical Trial Site, Strasbourg, France

  • Clinical Trial Site, Toulouse, France

  • Clinical Trial Site, Berlin, Germany

  • Clinical Trial Site, Cologne, Germany

  • Clinical Trial Site, Göttingen, Germany

  • Clinical Trial Site, Hanover, Germany

  • Clinical Trial Site, Heidelberg, Germany

  • Clinical Trial Site, Leipzig, Germany

  • Clinical Trial Site, Magdeburg, Germany

  • Clinical Trial Site, Munich, Germany

  • Clinical Trial Site, Münster, Germany

  • Clinical Trial Site, Würzburg, Germany

  • Clinical Trial Site, Athens, Greece

  • Clinical Trial Site, Athens, Greece

  • Clinical Trial Site, Heraklion, Greece

  • Clinical Trial Site, Thessaloniki, Greece

  • Clinical Trial Site, Hong Kong, Hong Kong

  • Clinical Trial Site, Balatonfüred, Hungary

  • Clinical Trial Site, Budapest, Hungary

  • Clinical Trial Site, Be’er Ya‘aqov, Israel

  • Clinical Trial Site, Haifa, Israel

  • Clinical Trial Site, Jerusalem, Israel

  • Clinical Trial Site, Petah Tikva, Israel

  • Clinical Trial Site, Ancona, Italy

  • Clinical Trial Site, Bologna, Italy

  • Clinical Trial Site, Brescia, Italy

  • Clinical Trial Site, Florence, Italy

  • Clinical Trial Site, Forlì, Italy

  • Clinical Trial Site, Lecce, Italy

  • Clinical Trial Site, Milan, Italy

  • Clinical Trial Site, Naples, Italy

  • Clinical Trial Site, Padova, Italy

  • Clinical Trial Site, Pavia, Italy

  • Clinical Trial Site, Pisa, Italy

  • Clinical Trial Site, Rimini, Italy

  • Clinical Trial Site, Roma, Italy

  • Clinical Trial Site, Rome, Italy

  • Clinical Trial Site, Torino, Italy

  • Clinical Trial Site, Bunkyō City, Japan

  • Clinical Trial Site, Fukuoka, Japan

  • Clinical Trial Site, Fukuoka, Japan

  • Clinical Trial Site, Kagawa, Japan

  • Clinical Trial Site, Kashihara, Japan

  • Clinical Trial Site, Kobe, Japan

  • Clinical Trial Site, Kumamoto, Japan

  • Clinical Trial Site, Kurume, Japan

  • Clinical Trial Site, Matsumoto-shi, Japan

  • Clinical Trial Site, Nagoya, Japan

  • Clinical Trial Site, Nankoku, Japan

  • Clinical Trial Site, Niigata, Japan

  • Clinical Trial Site, Okayama, Japan

  • Clinical Trial Site, Sapporo, Japan

  • Clinical Trial Site, Sapporo, Japan

  • Clinical Trial Site, Sendai, Japan

  • Clinical Trial Site, Suita, Japan

  • Clinical Trial Site, Tokyo, Japan

  • Clinical Trial Site, Kajang, Malaysia

  • Clinical Trial Site, Kuala Lumpur, Malaysia

  • Clinical Trial Site, Eindhoven, Netherlands

  • Clinical Trial Site, Groningen, Netherlands

  • Clinical Trial Site, Maastricht, Netherlands

  • Clinical Trial Site, Rotterdam, Netherlands

  • Clinical Trial Site, Utrecht, Netherlands

  • Clinical Trial Site, Christchurch, New Zealand

  • Clinical Trial Site, Hamilton, New Zealand

  • Clinical Trial Site, Ålesund, Norway

  • Clinical Trial Site, Lørenskog, Norway

  • Clinical Trial Site, Carnaxide, Portugal

  • Clinical Trial Site, Creixomil, Portugal

  • Clinical Trial Site, Leiria, Portugal

  • Clinical Trial Site, Lisbon, Portugal

  • Clinical Trial Site, Lisbon, Portugal

  • Clinical Trial Site, Vila Real, Portugal

  • Clinical Trial Site, Viseu, Portugal

  • Clinical Trial Site, Bucharest, Romania

  • Clinical Trial Site, Cluj-Napoca, Romania

  • Clinical Trial Site, Košice, Slovakia

  • Clinical Trial Site, Incheon, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, Seoul, South Korea

  • Clinical Trial Site, A Coruña, Spain

  • Clinical Trial Site, Barcelona, Spain

  • Clinical Trial Site, Barcelona, Spain

  • Clinical Trial Site, Bilbao, Spain

  • Clinical Trial Site, El Palmar, Spain

  • Clinical Trial Site, Huelva, Spain

  • Clinical Trial Site, Jaén, Spain

  • Clinical Trial Site, L'Hospitalet de Llobregat, Spain

  • Clinical Trial Site, Lleida, Spain

  • Clinical Trial Site, Madrid, Spain

  • Clinical Trial Site, Madrid, Spain

  • Clinical Trial Site, Palma de Mallorca, Spain

  • Clinical Trial Site, Pamplona, Spain

  • Clinical Trial Site, Salamanca, Spain

  • Clinical Trial Site, Santiago de Compostela, Spain

  • Clinical Trial Site, Valencia, Spain

  • Clinical Trial Site, Valencia, Spain

  • Clinical Trial Site, Vigo, Spain

  • Clinical Trial Site, Gothenburg, Sweden

  • Clinical Trial Site, Lund, Sweden

  • Clinical Trial Site, Solna, Sweden

  • Clinical Trial Site, Basel, Switzerland

  • Clinical Trial Site, Geneva, Switzerland

  • Clinical Trial Site, Lucerne, Switzerland

  • Clinical Trial Site, Sankt Gallen, Switzerland

  • Clinical Trial Site, New Taipei City, Taiwan

  • Clinical Trial Site, Taichung, Taiwan

  • Clinical Trial Site, Taipei, Taiwan

  • Clinical Trial Site, Taipei, Taiwan

  • Clinical Trial Site, Antalya, Turkey (Türkiye)

  • Clinical Trial Site, Istanbul, Turkey (Türkiye)

  • Clinical Trial Site, Bellshill, United Kingdom

  • Clinical Trial Site, Birmingham, United Kingdom

  • Clinical Trial Site, Cardiff, United Kingdom

  • Clinical Trial Site, London, United Kingdom

  • Clinical Trial Site, London, United Kingdom

  • Clinical Trial Site, Manchester, United Kingdom

מובילי המחקר
  • Medical Director

    Study Director

    Alnylam Pharmaceuticals